Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Conference Call February 5, 2025 4:30 PM ET
Company Participants
Stephanie Diaz – IR Manager
Brian Lian – CEO and President
Greg Zante – CFO
Conference Call Participants
Ryan Deschner – Raymond James
Mike Ulz – Morgan Stanley
Asim Rana – Truist Securities
Jay Olson – Oppenheimer
Annabel Samimy – Stifel
Mayank Mamtani – B. Riley Securities
Biren Amin – Piper Sandler
Hardik Parikh – JPMorgan
Andy Hsieh – William Blair
Yale Jen – Laidlaw & Company
Justin Zelin – BTIG
Operator
Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, this conference call is being recorded today, February 5, 2025.
I would now like to turn the conference over to Viking’s Manager of Investor Relations, Stephanie Diaz. Please go ahead, Stephanie.
Stephanie Diaz
Hello, and thank you all for participating in today’s call. Joining me today is Brian Lian, Viking’s President and CEO; and Greg Zante, Viking’s CFO.
Before we begin, I’d like to caution that comments made during this conference call today, February 5, 2025, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 including statements about Viking’s expectations regarding its development activities, time lines and milestones. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and adversely and reported results should not be considered as an indication of future performance.
These forward-looking statements speak only as of today’s date, and the company undertakes no obligation to revise or update any statement made today. I encourage you to review all of the company’s filings with
Credit: Source link
